152 related articles for article (PubMed ID: 35309313)
21. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.
Mensah F; Bansal A; Berkovitz S; Sharma A; Reddy V; Leandro MJ; Cambridge G
Clin Exp Immunol; 2016 May; 184(2):237-47. PubMed ID: 26646713
[TBL] [Abstract][Full Text] [Related]
22. Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Gravelsina S; Nora-Krukle Z; Vilmane A; Svirskis S; Vecvagare K; Krumina A; Murovska M
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439855
[TBL] [Abstract][Full Text] [Related]
23. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from?
Toogood PL; Clauw DJ; Phadke S; Hoffman D
Pharmacol Res; 2021 Mar; 165():105465. PubMed ID: 33529750
[TBL] [Abstract][Full Text] [Related]
24. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
Bested AC; Marshall LM
Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
[TBL] [Abstract][Full Text] [Related]
25. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
[TBL] [Abstract][Full Text] [Related]
26. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Esfandyarpour R; Kashi A; Nemat-Gorgani M; Wilhelmy J; Davis RW
Proc Natl Acad Sci U S A; 2019 May; 116(21):10250-10257. PubMed ID: 31036648
[TBL] [Abstract][Full Text] [Related]
27. Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Marshall-Gradisnik S; Johnston S; Chacko A; Nguyen T; Smith P; Staines D
J Int Med Res; 2016 Dec; 44(6):1381-1394. PubMed ID: 27834303
[TBL] [Abstract][Full Text] [Related]
28. Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.
Brenu EW; van Driel ML; Staines DR; Ashton KJ; Ramos SB; Keane J; Klimas NG; Marshall-Gradisnik SM
J Transl Med; 2011 May; 9():81. PubMed ID: 21619669
[TBL] [Abstract][Full Text] [Related]
29. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
[TBL] [Abstract][Full Text] [Related]
30. Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome.
Scherbakov N; Szklarski M; Hartwig J; Sotzny F; Lorenz S; Meyer A; Grabowski P; Doehner W; Scheibenbogen C
ESC Heart Fail; 2020 Jun; 7(3):1064-1071. PubMed ID: 32154656
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome With Partial Least Squares Discriminant Analysis: Relevance of Blood Extracellular Vesicles.
González-Cebrián A; Almenar-Pérez E; Xu J; Yu T; Huang WE; Giménez-Orenga K; Hutchinson S; Lodge T; Nathanson L; Morten KJ; Ferrer A; Oltra E
Front Med (Lausanne); 2022; 9():842991. PubMed ID: 35433768
[TBL] [Abstract][Full Text] [Related]
32. Case definitions and diagnostic criteria for Myalgic Encephalomyelitis and Chronic fatigue Syndrome: from clinical-consensus to evidence-based case definitions.
Morris G; Maes M
Neuro Endocrinol Lett; 2013; 34(3):185-99. PubMed ID: 23685416
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr Virus dUTPase Induces Neuroinflammatory Mediators: Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Williams PhD MV; Cox B; Lafuse PhD WP; Ariza ME
Clin Ther; 2019 May; 41(5):848-863. PubMed ID: 31040055
[TBL] [Abstract][Full Text] [Related]
34. The role of low-grade inflammation in ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) - associations with symptoms.
Jonsjö MA; Olsson GL; Wicksell RK; Alving K; Holmström L; Andreasson A
Psychoneuroendocrinology; 2020 Mar; 113():104578. PubMed ID: 31901625
[TBL] [Abstract][Full Text] [Related]
35. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
Strassheim VJ; Sunnquist M; Jason LA; Newton JL
BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
[TBL] [Abstract][Full Text] [Related]
36. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data.
Maes M; Twisk FN; Johnson C
Psychiatry Res; 2012 Dec; 200(2-3):754-60. PubMed ID: 22521895
[TBL] [Abstract][Full Text] [Related]
37. Cell-Based Blood Biomarkers for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Missailidis D; Sanislav O; Allan CY; Annesley SJ; Fisher PR
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046336
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME).
Petty RD; McCarthy NE; Le Dieu R; Kerr JR
PLoS One; 2016; 11(3):e0150904. PubMed ID: 26967895
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Gender Differences in HRV of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Mobile-Health Technology.
Capdevila L; Castro-Marrero J; Alegre J; Ramos-Castro J; Escorihuela RM
Sensors (Basel); 2021 May; 21(11):. PubMed ID: 34071326
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
de Vega WC; Herrera S; Vernon SD; McGowan PO
BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
